Commission Regulation (EU) 2021/418 of 9 March 2021 amending Directive 2002/46/EC of the European Parliament and of the Council as regards nicotinamide riboside chloride and magnesium citrate malate used in the manufacture of food supplements and as regards the units of measurement used for copper (Text with EEA relevance)

• CELEX: Regulation (EU) 2021/418
• Articles: 5

Article 1

Annex I to Directive 2002/46/EC is amended in accordance with the Annex to this Regulation.

Article 2

Annex II to Directive 2002/46/EC is amended in accordance with the Annex to this Regulation.

Article 3

Products placed on the market or labelled prior to 30 September 2022 and that do not comply with point 1 of the Annex to this Regulation may be marketed after that date until the existing stocks run out.

Article 4

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Article 1 shall apply from 30 September 2022.

Schedules & Appendices

ANNEX

ANNEX

Directive 2002/46/EC is amended as follows:

(1)

in point 2 of Annex I to Directive 2002/46/EC the entry ‘Copper (μg)’ is replaced by the following:

‘Copper (mg)’;

(2)

Annex II is amended as follows:

(a)

in point A.7. NIACIN the following entry is added after the entry for ‘inositol hexanicotinate (inositol hexaniacinate)’:

‘(d)

nicotinamide riboside chloride’;

(b)

in point B the following entry is added after the entry ‘magnesium chloride’:

‘magnesium citrate malate’.